-transparent.png){kind=logo}
In order to assess the value and therapeutic safety of an antiarrhythmic drug, it must be submitted to multiple tests, which reproduce as faithfully as possible the conditions observed in human pathology. The main experimental approaches are presented here: screening and control tests. For each test, the authors emphasize the various experimental factors limiting their interpretation and allowing the extrapolation to men.
Related Publications
H Vainsel, and
L Dodion, and
R Bernard, and
H Denolin
November 1985,
Nihon rinsho. Japanese journal of clinical medicine,
H Vainsel, and
L Dodion, and
R Bernard, and
H Denolin
January 1996,
Zeitschrift fur Kardiologie,
H Vainsel, and
L Dodion, and
R Bernard, and
H Denolin
January 1977,
Agents and actions. Supplements,
H Vainsel, and
L Dodion, and
R Bernard, and
H Denolin
January 1970,
Minerva anestesiologica,
H Vainsel, and
L Dodion, and
R Bernard, and
H Denolin
March 1970,
Soins; la revue de reference infirmiere,
H Vainsel, and
L Dodion, and
R Bernard, and
H Denolin
December 1975,
Semaine des hopitaux. Therapeutique,
H Vainsel, and
L Dodion, and
R Bernard, and
H Denolin
January 1983,
Archivos del Instituto de Cardiologia de Mexico,
H Vainsel, and
L Dodion, and
R Bernard, and
H Denolin
January 1975,
Farmakologiia i toksikologiia,
H Vainsel, and
L Dodion, and
R Bernard, and
H Denolin
January 1959,
Rassegna di fisiopatologia clinica e terapeutica,
H Vainsel, and
L Dodion, and
R Bernard, and
H Denolin
January 1984,
Revista espanola de cardiologia,
